S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development of cancer. The use of selenium may be an effective way to prevent prostate cancer
in patients who have neoplasia of the prostate.
PURPOSE: Randomized phase III trial to study the effectiveness of selenium in preventing
prostate cancer in patients who have neoplasia of the prostate.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI)